Last $5.16 USD
Change Today -0.02 / -0.39%
Volume 294.3K
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel N. Swisher Jr.

Chief Executive Officer, President and Director, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
49$1,174,222
As of Fiscal Year 2012

Background*

Mr. Daniel N. Swisher, Jr., also known as Dan, has been the Chief Executive Officer of Sunesis Pharmaceuticals Inc., since January 2004 and has been its President since August 2005. Mr. Swisher joined Sunesis Pharmaceuticals in January 2002 and served as its Chief Business Officer & Chief Financial Officer from December 2001 to December 2003. He served as Chief Operating Officer of Sunesis. He has more than 15 years of experience in pharmaceutical product development, ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

2004-Present
Chief Executive Officer, President and Director
2011-Present
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
Yale University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$431,894
Total Annual Compensation$431,894

Stock Options*

All Other Compensation$3,130
Exercisable Options582,096
Unexercisable Options826,042
Total Number of Options1,408,138

Total Compensation*

Total Annual Cash Compensation$652,024
Total Short Term Compensation$431,894
Other Long Term Compensation$3,130
Total Calculated Compensation$1,174,222
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $5.16 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John R. Plachetka Pharm D.Co-Founder, Chairman, Chief Executive Officer and President
POZEN Inc.
$574.5K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.